Stearoyl-CoA desaturase 1 inhibitor supplemented with gemcitabine treatment cuts down the viability and fatty acid content of pancreatic most cancers cells in vitro A lot of medicines target lipid reprogramming. On the other hand, only a few medicines have achieved clinical trials. We summarize the common drugs that focus on https://courtneyg777zkw9.elbloglibre.com/profile